Introduction {#Sec1}
============

Glutamate, the primary excitatory neurotransmitter in the mammalian brain, plays a key role in seizure generation and epilepsy. Pharmacological inhibition of glutamatergic neurotransmission provides protection against seizures in a host of experimental models \[[@CR1]\]. Blockade of the NMDA receptor by different classes of selective antagonists protects against cocaine-induced convulsions \[[@CR2]--[@CR7]\]. Furthermore, NMDA receptor antagonists inhibit the expression and development of cocaine-kindled seizures \[[@CR8], [@CR9]\].

A pivotal role of glutamatergic neurotransmission has been demonstrated in seizure kindling models and numerous reports indicate altered expression of glutamate receptors in various brain regions of kindled-animals \[for review see Löscher, [@CR10]\]. Moreover, the extracellular levels of glutamate are elevated in various brain regions of fully-kindled animals \[[@CR11]--[@CR15]\]. These changes are thought to underlie the development of seizure kindling in various models.

Cocaine kindling is characterized by increased seizure response to subsequent administrations of the drug \[[@CR16], [@CR17]\]. This paradigm is akin to other well characterized models of kindling, i.e. amygdala- or PTZ-kindled seizures \[[@CR18], [@CR19]\]. However, glutamatergic neurotransmission is relatively less characterized in this model and important questions remain as to the role of glutamate in cocaine kindled seizures. In the present report, we studied the changes in mRNA and protein expression of NMDA receptor subunits, NR1 and NR2B, together with quantitative \[^3^H\] MK-801 autoradiography in mice kindled by repeated administration of cocaine. Basal and depolarization-induced glutamate overflow was quantified in control and cocaine-kindled mice using in vivo brain microdialysis.

Experimental Procedure {#Sec2}
======================

Animals {#Sec3}
-------

Male Swiss Webster mice (Taconic Farms, Germantown, NY), weighing 25--35 g, were housed five per cage with free access to food and water. Mice were kept in a vivarium under controlled laboratory conditions (temperature 22--26°C, humidity 40--50%) with an artificial 12-h light/dark cycle. All animals were allowed to acclimate for at least 5 days before testing. The experimental groups consisted of 6--8 animals. The experiments were performed during the light cycle after at least 30-min acclimation to the experimental room. Mice were returned to their home cage and placed in the vivarium after daily testing.

Animals used in these studies were maintained in facilities fully accredited by the American Association for Accreditation of Laboratory Animal Care and were tested under approved protocols from the Animal Care and Use Committee of the National Institute of Drug Abuse, under guidance by the Guide for Care and Use of Laboratory Animals (National Research Council, 1996, National Academy Press, Washington, DC).

Treatment {#Sec4}
---------

The animals were kindled with cocaine (National Institute on Drug Abuse, Baltimore, MD) at a dose of 60 mg/kg (i.p.; one injection per day) for 5 consecutive days as described by Miller et al. \[[@CR16]\]. Each day immediately following cocaine injection every mouse was individually placed in Plexiglas containers (14 × 25 × 36 cm) for observation. The presence of convulsions was recorded for 30 min following injection. Cocaine-induced convulsions were defined as the occurrence of clonic seizures accompanied by loss of the righting reflex for at least 5 s. The development of kindling was reflected by monotonic and statistically significant increases in the number of mice exhibiting seizures upon repeated treatments with cocaine \[[@CR16]\]. After a 5-day washout, when the susceptibility to the convulsant effect of cocaine is still significantly increased \[[@CR16]\], the mice were sacrificed and their brains were removed for receptor studies (described below). Another group of animals was kindled under the same protocol and used for microdialysis studies after the 5-day washout from cocaine (described below). Control animals always received i.p. saline injections instead of cocaine and underwent the same experimental manipulations as cocaine-kindled groups.

Preparation of Brain Tissue {#Sec5}
---------------------------

The animals were sacrificed 5 days after a 5-day cocaine washout and their brains were removed rapidly, quickly frozen on dry ice, and stored at −70°C. Twelve-μm thick tissue sections were cut in a cryostat (Shandon, UK) and thaw-mounted onto poly-L-lysine-coated microscope slides. Sections were taken at a level of hippocampus and striatum. Slide mounted sections were stored in slide boxes at −70°C until used in assays.

Quantitative Autoradiography of \[^3^H\] MK-801 {#Sec6}
-----------------------------------------------

On the day of the experiment, before incubation, frozen tissue sections were slowly warmed in a refrigerator (4°C) then thoroughly blown dry with cool air for 5 min. Sections were preincubated (pre-wash) in a 5 mM Tris--Hcl buffer (pH 7.4) containing 2.5 mM CaCl~2~ at 5°C for 10 min. Subsequently, they were incubated in a 5 mM Tris--Hcl buffer (pH 7.4) containing 5 µM spermidine, 5 µM L-glycine, 5 µM glutamate and 6 µM \[^3^H\]MK-801 (NEN; sp. act. 61 Ci/mmol) for 90 min at room temperature. Non-specific binding was determined as binding in the presence of 100 μM unlabeled MK-801. After incubations sections were washed 3 times in fresh, ice-cold 5 mM Tris--Hcl buffer (pH 7.4) then in ice-cold water and twice in ice-cold 2.5% glutaraldehyde in acetone and then dried in a stream of cold air. All sections were placed in boxes along with desiccant overnight before being placed into cassettes with tritium-sensitive film. Dried sections were exposed to \[^3^H\] Hyperfilm (Amersham) along with tritium standards and stored in an X-ray film cassette for 4 weeks at 4°C. Autoradiograms were developed with Kodak D-19 developer and fixed with Kodak Fixer at 18°C. Quantification analysis of the resulting autoradiographic images was performed by using the MCID image analysis system (Imaging Research Inc., Canada). The obtained values were compared by Student's *t*-test.

In Situ Hybridization {#Sec7}
---------------------

A series of five consecutive coronal sections (12 μm-thick) was thaw-mounted onto chromalum-pretreated slices, postfixed in a 4% formaldehyde for 10 min, and processed for in situ hybridization according to Young et al. \[[@CR20]\]. The anti-sense NR1 and NR2B oligonucleotide probes were complementary to bases 375--420 of the rat NR1 cDNA \[[@CR21]\] and to bases 557--572 of the rat NR2B receptor mRNA \[[@CR22]\]. Probes were labeled using \[^35^S\] dATP (1,200 Ci/mmol, NEN) to obtain a specific activity of about 2 × 10^6^ Ci/mol. Pre-hybridization treatment consisted of acetylation and dehydration. The sections were then hybridized with NR1 and NR2B oligonucleotide probe (1 × 10^6^ c.p.m./25 µl) for 20 h at 37°C in a humidified incubator. After washing at 40°C, the sections were exposed to a Hyperfilm MP (Amersham) at room temperature for 21 days. After hybridization, washing out and autoradiography of the brain slices, quantification of the signals on film was performed using MCID image analysis system (Imaging Research Inc., Canada). Hybridization of the NR1 and NR2B oligonucleotide probes was recorded as a mean density after subtraction of the film background density. The mean optical density values were obtained by averaging the measurements from autoradiograms of the brain sections, obtained from six animals. The obtained values were compared by Student's *t*-test.

Western Blotting {#Sec8}
----------------

Frontal cerebral cortex, hippocampus and striatum were dissected from mice brain and were stored at −80°C until processing. The tissue was homogenized in 20 volumes of ice-cold 0.32 M sucrose at 0°C, centrifuged at 1,000×*g* for 10 min at 4°C and the supernatant was then centrifuged at 10,000×*g* for 20 min at 4°C. The membrane pellet was resuspended and washed in 30 volumes of 50 mM Tris--Hcl (pH = 7.4) and the final pellet (resuspended in 7 volumes of buffer) was used for Western blot analysis \[[@CR23]\]. The protein concentration was determined by the method of Lowry et al. \[[@CR24]\]. Aliquots of 10 µg of protein per line (cerebral cortex, hippocampus) or 15 µg of protein per line (striatum) were separated by 7% SDS-PAGE and transferred to polyvinylidene fluoride membranes (PVDF Western Blotting Membranes, Boehringer Mannheim, Germany). Blots were incubated overnight at 4°C with rabbit anti-glutamate receptor NR1 (1:2,500; Sigma, Saint Louis, USA) or with rabbit anti-glutamate receptor NR2B (RBI, Natick, USA) followed by incubation for 30 min at room temperature with horseradish peroxidase-conjugated anti-rabbit secondary antibodies (40 mU/ml, Boehringer Mannheim, Germany). Proteins were visualized with enhanced chemiluminescence (BM Chemiluminescence Western Blotting Kit, Boehringer Mannheim, Germany). The relative changes in the protein levels were evaluated by measuring the intensity of the immunoreactive bands using the Image Gauge ver. 3.11 system (FUJI Medical Systems, USA). The obtained values were compared by Student's *t*-test.

In Vivo Microdialysis {#Sec9}
---------------------

Upon completion of cocaine-kindling (24 h after the last cocaine injection) animals were anesthetized with sodium pentobarbital (75 mg/kg i.p.) and placed in a stereotaxic frame (David Kopf, Topanga, CA) adapted for the mouse. A microdialysis guide cannula (CMA11, CMA/Microdialysis, North Chelmsford, MA) was aimed at the ventral hippocampus, according to the atlas of Paxinos and Franklin \[[@CR25]\]. The coordinates, relative to bregma, were: P: −2.8 mm, L: ±3.0 mm, V: −2.0 mm, calculated for 2 mm membrane length probes. The guide cannula was fixed to the skull with cranioplastic cement (Geristore, Santa Maria, CA) and secured with dental acrylic (Lang Dental MGF. Inc., Wheeling, Illinois). After surgery, mice were individually housed in the animal facility room for recovery. Animals were given a 4 days recovery period after surgery, prior to the commencement of the experiment. Twelve hours before starting the experiments, microdialysis probes (CMA/11, CMA Microdialysis, North Chelmsford, MA) were connected to the microinfusion pump (CMA/102) via a quartz-lined, low resistance swivel (375/D/22QM, Instech, Plymouth Meeting, PA) and flushed with an artificial cerebrospinal fluid (aCSF: 145 mM NaCl, 2.8 mM KCl, 1.2 mM Ca~2~Cl, 1.2 mM Mg~2~Cl, 5.4 mM D-glucose, pH 7.2 adjusted with NaOH 0.5 M). Probes were then slowly inserted into the guide cannulae and mice were placed into the plexiglass chambers where food and water were freely available. The probes were perfused overnight at a flow rate of 0.6 µl/min. The next morning and after a 1.5 h equilibration period with fresh aCSF, dialysis samples were collected every 10 min. Three basal samples were collected. The aCSF was switched to an aCSF containing 0.6 mM of the selective glutamate transporter inhibitor, L-trans-pyrrolidine-2,4-dicarboxylic acid (tPDC; Sigma) \[[@CR26]\]. Four dialysate samples were then collected for determination of potassium-evoked glutamate levels. A high-K^+^ aCSF (100 mM KCl) containing 0.6 mM of tPDC was perfused and 4 additional samples were collected \[[@CR27]\].

Analysis of Dialysate Glutamate Levels {#Sec10}
--------------------------------------

Glutamate levels were quantified using a pre-column derivatization reaction with [o]{.smallcaps}-Phthalaldehyde followed by HPLC with fluorimetric detection. Briefly, 4 µl of dialysate samples were diluted in 13 µl of borax (pH 10.5). Then, 3 µl of derivatizing reagent (0.4 M borate, 40 μM o-Phthaldialdehyde and 0.4 M 2-mercaptoethanol) was added. After a 60 s reaction period, derivatized sample was injected with a CMA/200 refrigerated microinjector (CMA Microdialysis, North Chelmsford, MA) into the HPLC system. Separation of glutamate was achieved by using a BAS microbore C18 column (100 × 1 mm, 5 µm). The mobile phase (0.1 M sodium acetate, 6% acetonitrile (v/v), adjusted to pH 6.0, filtered through a 0.22 µm nylon filter and degassed) was pumped with a BAS PM-80 pump (BAS, West Lafayette, IN) at a flow rate of 160 µl/min, that was achieved through a splitter-flow restrictor. Glutamate was detected using a BAS Fluorescence detector (FL-45) with the following wavelengths settings: excitation---330 ηm and emission---440 ηm. Neurotransmitter dialysate levels were quantified by external standard curve calibration. Limit of detection was 0.1 µM. The results are expressed in µM as means ± SEM. The area under the curve was calculated for each treatment group and compared by Student's *t*-test.

Results {#Sec11}
=======

Quantitative autoradiography of \[^3^H\] MK-801 did not reveal changes in radioligand binding to any brain region of cocaine-kindled mice. Thus, comparable values were obtained in control and cocaine-kindled mice in hippocampus (both CA1 and CA3 regions), nucleus accumbens (both shell and core), dorsolateral and ventromedial striatum, sensory, motor and cingulate cortex (Table [1](#Tab1){ref-type="table"}).Table 1Effect of cocaine kindling on specific binding of \[^3^H\] MK-801 to mouse brain structures in cocaine kindled and control miceBrain structureControl (optical density units)Cocaine-kindled (optical density units)HPC-CA127.3 ± 7.332.0 ± 8.0HPC-CA326.7 ± 8.627.2 ± 6.1N. ACC---shell9.5 ± 4.210.1 ± 4.9N. ACC---core16.2 ± 5.616.9 ± 5.0ST-DL16.3 ± 5.017.8 ± 4.9ST-VM17.6 ± 5.319.2 ± 5.1Sensory cortex37.3 ± 12.537.5 ± 11.6Motor cortex36.0 ± 11.540.1 ± 8.6Cingulate cortex48.0 ± 15.954.8 ± 8.0Values (optical density units) are given as mean ± SEM from 6 animals. *HPC*-*CA1* hippocampus (CA1 region), *HPC*-*CA3* hippocampus (CA3 region), *N. ACC*---*shell* nucleus accumbens (shell), *N. ACC*---*core* nucleus accumbens (core), *ST*-*DL* dorsolateral striatum, *ST*-*VM* ventromedial striatum. The obtained values were compared between control and cocaine-kindled groups by Student's *t*-test. No statistically significant differences were observed (*P* \> 0.05)

In situ mRNA hybridization of NR1 and NR2B subunits measured in hippocampus, striatum and frontal cortex also remained unaltered in cocaine-kindled mice in comparison to control group (Table [2](#Tab2){ref-type="table"}). Finally, protein levels of NR1 and NR2B subunits were unchanged by cocaine-kindling as indicated by quantitative Western blotting (Table [3](#Tab3){ref-type="table"}).Table 2In situ mRNA hybridization of NR1 and NR2B subunits of NMDA receptors in different brain regions of cocaine kindled and control miceBrain structureControl (optical density units)Cocaine-kindled (optical density units)NR1 HPC-CA10.26 ± 0.040.29 ± 0.05 HPC-CA30.28 ± 0.050.34 ± 0.05 HPC-DG0.28 ± 0.030.31 ± 0.04 Striatum0.11 ± 0.010.14 ± 0.01 Frontal cortex0.13 ± 0.020.16 ± 0.01NR2B HPC-CA10.087 ± 0.0070.081 ± 0.006 HPC-CA30.096 ± 0.0060.096 ± 0.006 HPC-DG0.138 ± 0.0090.127 ± 0.010 Striatum0.030 ± 0.0010.038 ± 0.004 Frontal cortex0.037 ± 0.0010.037 ± 0.003Values (optical density units) are given as mean ± SEM from 6 animals. Abbreviations used: *HPC*-*CA1* hippocampus (CA1 region); *HPC*-*CA3* hippocampus (CA3 region), *HPC*-*DG* hippocampus (dentate gyrus). *e* nucleus accumbens (core), *ST*-*DL* dorsolateral striatum, *ST*-*VM* ventromedial striatum. The obtained values were compared between control and cocaine-kindled groups by Student's *t*-test. No statistically significant differences were observed (*P* \> 0.05)Table 3Protein levels of NR1 and NR2B subunits of NMDA receptors measured by Western blotting in cocaine kindled and control miceBrain structureControl (optical density units)Cocaine-kindled (optical density units)NR1 Hippocampus99,754 ± 26,162116,742 ± 19,359 Striatum145,738 ± 42,600159,528 ± 50,676 Frontal Cortex94,368 ± 7,45588,786 ± 10,390NR2B Hippocampus152,540 ± 5,464172,300 ± 11,248 Striatum260,620 ± 48,487252,520 ± 84,450 Frontal cortex110,600 ± 3,930108,496 ± 12,478Values (optical density units) are given as mean ± SEM from 6 animals. The obtained values were compared between control and cocaine-kindled groups by Student's *t*-test. No statistically significant differences were observed (*P* \> 0.05)

Microdialysis studies revealed no difference (*P* \> 0.05) between control and cocaine-kindled groups in basal glutamate overflow in the ventral hippocampus (Fig. [1](#Fig1){ref-type="fig"}a). Rapid transporter-mediated uptake may mask the detection of changes in glutamate release \[[@CR28]\], therefore a selective excitatory amino acid transporter inhibitor tPDC \[[@CR26]\] was added to the perfusion medium for subsequent studies. tPDC caused significant (approximately fivefold) increase of glutamate levels in both kindled and control mice (*P* \< 0.05) (Fig. [1](#Fig1){ref-type="fig"}a). However, the increase in glutamate levels caused by perfusion of tPDC was comparable in both groups of mice (Fig. [1](#Fig1){ref-type="fig"}a). In contrast, potassium-induced depolarization with co-perfusion of tPDC led to an increase of glutamate level (*P* \< 0.05) in cocaine-kindled animals as compared to control mice (Fig. [1](#Fig1){ref-type="fig"}b, c).Fig. 1Comparison of glutamate levels in the ventral hippocampus measured by brain microdialysis in freely moving cocaine-kindled and control mice. **a** basal glutamate levels during perfusion with normal aCSF and aCSF containing 0.6 mM of glutamate uptake inhibitor, tPDC. **b** high potassium-evoked levels of glutamate in the presence of tPDC in the perfusate. **c** area under the curve (AUC) calculated for the graph in **b**. \* *P* \< 0.05 versus control group (Student's *t*-test)

Discussion {#Sec12}
==========

Since NMDA antagonists display protective activity against both acute \[[@CR3]\] and chronic effects of cocaine-induced seizures \[[@CR8], [@CR9]\], we investigated whether NMDA receptors or presynaptic glutamate transmission is altered in cocaine-kindled mice. No significant alterations in the mRNA expression of NMDA receptor subunits or NMDA ligand binding were seen. Basal levels of glutamate also did not differ between kindled and control mice. However, perfusion of high-potassium aCSF together with tPDC revealed higher depolarization-evoked overflow of glutamate in cocaine-kindled mice.

Five days after completion of kindling, at the time when the susceptibility to cocaine-induced seizures is still increased \[[@CR16]\], we found no changes in NMDA receptor binding. This observation is in agreement with previously published data regarding binding of a non-competitive NMDA antagonist, \[^3^H\]MK-801, in rat brain membranes following cocaine kindling \[[@CR8]\]. However, binding of a competitive antagonist, \[^3^H\]CGP 39653, was significantly increased under the same conditions \[[@CR8], [@CR29]\]. Our results consistently show that in addition to the lack of changes in \[^3^H\]MK-801 binding assessed by quantitative autoradiography there were no changes in mRNA expression assessed by in situ hybridization and protein levels of key NMDA receptor subunits measured by Western blot. These results are in line with the fact that the expression of mRNA transcripts and protein for several NMDA receptor subunits is also not altered by electrical kindling \[[@CR30], [@CR31]\]. Together these findings indicate that cocaine kindled seizures, similarly to electrically kindled seizures, do not appear to be associated with changes in NMDA receptor expression. However, changes in expression of AMPA receptors have been reported during seizure kindling \[[@CR32]\] and AMPA receptors antagonists are efficacious against cocaine-induced seizures \[[@CR33]\]. Thus, it is possible that alteration in AMPA receptor expression may play a more important role in cocaine kindling, but this still remains to be determined.

Basal levels of glutamate measured by microdialysis are generally elevated in several brain regions of electrically- and chemically-kindled animals \[[@CR11]--[@CR14]\]. However, a study of Ueda and Tsuru \[[@CR34]\] reported elevated glutamate levels in amygdala kindled animals, which was present for only few minutes after electrical stimulation. Basal levels of this neurotransmitter in the ventral hippocampus remained unaltered throughout kindling acquisition and in fully-kindled rats \[[@CR34]\]. Our study is the first to measure extracellular glutamate levels in cocaine-kindled animals. Similarly to the report by Ueda and Tsuru \[[@CR34]\] we have found no changes in basal level of glutamate in this brain region. Perfusion with tPDC caused a several fold increase in glutamate levels as previously reported by Herrera-Marschitz, \[[@CR27]\]. Although no difference between kindled and control mice in glutamate level measured under these conditions was observed, co-perfusion of a depolarizing concentration of K^+^ with tPDC produced a significantly greater increase in glutamate overflow in cocaine-kindled mice versus control group. This observation is consistent with several studies performed in epileptic animals where the enhancement of depolarization stimulated glutamate release has been observed \[[@CR12], [@CR31], [@CR35], [@CR36]\]. Similar findings have been obtained in vitro in tissue obtained from patients with temporal lobe epilepsy \[[@CR36]\]. It has been demonstrated that under basal conditions the uptake of glutamate from the extracellular space is very rapid, however when uptake transport is inhibited by tPDC then changes in glutamate release can be unmasked \[[@CR28]\]. Collectively, these results indicate that depolarization-dependent release of glutamate is enhanced as a consequence of seizure kindling with cocaine. Future studies will determine whether similar mechanisms could also be responsible for alteration of seizure threshold after withdrawal from repeated administration of cocaine at sub-convulsant doses.

Changes in glutamatergic neurotransmission and alterations in glutamate receptor expression are thought to play an important role in the development of drug abuse, behavioral sensitization and withdrawal symptoms \[[@CR37], [@CR38]\]. Our data strongly suggest that glutamate neurotransmission is also enhanced as a consequence of cocaine-kindled seizures and may play an important role in this process.
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